MedPath

Efficacy of a Mobile Phone App for Depression and Anxiety in College Students

Not Applicable
Conditions
Depressive Symptoms
Anxiety Symptoms
Interventions
Device: VamosJuntxs App
Other: Web Conciencia Saludable
Registration Number
NCT06628830
Lead Sponsor
University of Chile
Brief Summary

The goal of this clinical trial is to evaluate the efficacy of a mobile phone application for the early intervention of depression and anxiety among young university students in Chile. The main question it aims to answer is:

- Can a mobile app reduce depressive and anxious symptomatology in college students?

Researchers will compare the intervention arm (mobile app users) to the control group (receives psychoeducational material and mental health care resources) to see if the app leads to significant improvements in depressive and anxious symptoms and well-being.

Participants will:

* Be randomly assigned to either the intervention or control group.

* Use the mobile application, which includes psychoeducational materials, cognitive-behavioral therapy modules, and periodic personalized feedback.

* Complete assessments at baseline, post-intervention, and 3 and 6 months after randomization using online tools such as the PHQ-9 for depressive symptoms and the GAD-7 for anxious symptoms.

Detailed Description

Not available

Recruitment & Eligibility

Status
ENROLLING_BY_INVITATION
Sex
All
Target Recruitment
200
Inclusion Criteria
  • PHQ-9 and GAD-7 score between 5 and 14 points
  • Have a stable internet connection
  • To provide informed consent
Exclusion Criteria
  • High risk of suicide according to C-SSRS
  • Currently undergoing psychological, psychiatric and/or psychopharmacological treatment
  • Bipolar disorder, psychotic disorder or substance use disorder assessed with the respective modules of the MINI interview.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Intervention GroupVamosJuntxs AppThe intervention consists of an indicated prevention program delivered through a mobile app. The program will last 6 weeks and includes the following: 1. Psychoeducation on depression and anxiety 2. CBT skills training 3. mood and symptom monitoring and feedback: mood tracker and the application every two weeks of the PHQ-4 and question 9 of the PHQ-9 4. Chat with a psychologist (on demand) 5. Optional modules on other related mental health topics (e.g. healthy habits, relaxation, mindfulness) Additionally, participants will be able to access additional help resources that include a speed dial button for a suicide prevention hotline and a web link to access contact information for mental health services. Finally, the intervention protocol also includes the eventual referral to face-to-face mental health care if required.
Control GroupWeb Conciencia SaludableParticipants in the enhanced control group will receive a web link (https://concienciasaludable.uchile.cl/) with information about places to go to seek mental health care both inside and outside the respective university and psychoeducational material on depression and anxiety
Primary Outcome Measures
NameTimeMethod
Depression symptoms6-weeks post-randomization

PHQ-9, total score varies between 0 and 27, higher values represent a worse outcome

Anxiety symptoms6-weeks post-randomization

GAD-7, total score varies between 0 and 21, higher values represent a worse outcome

Secondary Outcome Measures
NameTimeMethod
Well-being6-months post-randomization

The Warwick-Edinburgh Mental Well-being Scale (WEMWBS), total score varies between 7 and 35, higher values represent a better outcome

User Satisfaction6-weeks post-randomization

Ad-hoc satisfaction questionnaire for the intervention group, total score varies between 7 and 28, higher values represent a better outcome and an overall index with values ranging from 1 to 10

Depression symptoms6-months post-randomization

PHQ-9, total score varies between 0 and 27, higher values represent a worse outcome

Anxiety symptoms6-months post-randomization

GAD-7, total score varies between 0 and 21, higher values represent a worse outcome

Trial Locations

Locations (1)

CEMERA, Faculty of Medicine, Universidad de Chile

🇨🇱

Santiago, Region Metropolitana, Chile

© Copyright 2025. All Rights Reserved by MedPath